Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 Sep;58(3):565–570. doi: 10.1172/JCI108502

Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

J P Palmer, J W Benson, R M Walter, J W Ensinck
PMCID: PMC333214  PMID: 783201

Abstract

To determine if both phases of glucagon secretion are excessive in diabetes, arginine was admimistered intravenously as pulses and as infusions to normal subjects, insulin-dependent diabetics, and noninsulin-requiring diabetics. The acute phase of glucagon secretion, in response to arginine pulses at four different doses (submaximal to maximal alpha-cell stimulating), was indistinguishable in terms of timing, peak levels attained, and total increments comparing controls and diabetics. During the first half of the arginine infusion (500 mg/kg over 30 min) the glucagon rise in controls and diabetics was similar (P greater than 0.1), whereas during the last half of the infusion excessive glucagon levels were seen in the diabetics. No difference in the glucagon responses to arginine administered as either a pulse or an infusion was observed between the two types of diabetics. The acute phase responses of insulin to intravenous, maximal stimulating doses of glucose (20 g) and arginine (2.5 g) were measured in five insulin-independent diabetics. Although the acute insulin response to arginine was normal, there was marked attentuation of the early beta-cell response upon stimulation by glucose. From these results we conclude that although in diabetes excessive glucagon levels are observed with chronic arginine stimulation, the acute phase of glucagon secretion in response to arginine is normal. In addition, the beta-cell in noninsulin-requiring diabetics, although acutely hyporesponsive to glucose, remains normally responsive to another stimulus, arginine.

Full text

PDF
565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albisser A. M., Leibel B. S., Ewart T. G., Davidovac Z., Botz C. K., Zingg W. An artificial endocrine pancreas. Diabetes. 1974 May;23(5):389–396. doi: 10.2337/diab.23.5.389. [DOI] [PubMed] [Google Scholar]
  2. Albisser A. M., Leibel B. S., Ewart T. G., Davidovac Z., Botz C. K., Zingg W., Schipper H., Gander R. Clinical control of diabetes by the artificial pancreas. Diabetes. 1974 May;23(5):397–404. doi: 10.2337/diab.23.5.397. [DOI] [PubMed] [Google Scholar]
  3. Blackard W. G., Nelson N. C., Andrews S. S. Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions. Diabetes. 1974 Mar;23(3):199–202. doi: 10.2337/diab.23.3.199. [DOI] [PubMed] [Google Scholar]
  4. Cerasi E., Luft R., Efendic S. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes. 1972 Apr;21(4):224–234. doi: 10.2337/diab.21.4.224. [DOI] [PubMed] [Google Scholar]
  5. Deckert T. Insulin secretion following administration of secretin in patients with diabetes mellitus. Acta Endocrinol (Copenh) 1968 Sep;59(1):150–158. doi: 10.1530/acta.0.0590150. [DOI] [PubMed] [Google Scholar]
  6. Fajans S. S., Floyd J. C., Jr, Knopf R. F., Pek S., Weissman P., Conn J. W. Amino acids and insulin release in vivo. Isr J Med Sci. 1972 Mar;8(3):233–243. [PubMed] [Google Scholar]
  7. Felig P., Gusberg R., Hendler R., Gump F. E., Kinney J. M., Mulrow P. J. Concentrations of glucagon and the insulin:glucagon ratio in the portal and peripheral circulation. Proc Soc Exp Biol Med. 1974 Oct;147(1):88–90. doi: 10.3181/00379727-147-38286. [DOI] [PubMed] [Google Scholar]
  8. Frankel B. J., Gerich J. E., Fanska R. E., Gerritsen G. C., Grodsky G. M. Responses to arginine of the perfused pancreas of the genetically diabetic Chinese hamster. Diabetes. 1975 Mar;24(3):273–279. doi: 10.2337/diabetes.24.3.273. [DOI] [PubMed] [Google Scholar]
  9. Gerich J. E., Langlois M., Noacco C., Karam J. H., Forsham P. H. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science. 1973 Oct 12;182(4108):171–173. doi: 10.1126/science.182.4108.171. [DOI] [PubMed] [Google Scholar]
  10. Goodner C. J., Conway M. J., Werbach J. H. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose. J Clin Invest. 1969 Oct;48(10):1878–1887. doi: 10.1172/JCI106154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iversen J. Secretion of glucagon from the isolated, perfused canine pancreas. J Clin Invest. 1971 Oct;50(10):2123–2136. doi: 10.1172/JCI106706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lerner R. L., Porte D., Jr Acute and steady-state insulin responses to glucose in nonobese diabetic subjects. J Clin Invest. 1972 Jul;51(7):1624–1631. doi: 10.1172/JCI106963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lerner R. L., Porte D., Jr Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate. J Clin Endocrinol Metab. 1971 Sep;33(3):409–417. doi: 10.1210/jcem-33-3-409. [DOI] [PubMed] [Google Scholar]
  14. Lund B., Schmidt A., Deckert T. Portal and cubital serum insulin during oral, portal and cubital glucose tolerance tests. Acta Med Scand. 1975 Apr;197(4):275–281. doi: 10.1111/j.0954-6820.1975.tb04917.x. [DOI] [PubMed] [Google Scholar]
  15. Müller W. A., Faloona G. R., Aguilar-Parada E., Unger R. H. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med. 1970 Jul 16;283(3):109–115. doi: 10.1056/NEJM197007162830301. [DOI] [PubMed] [Google Scholar]
  16. Palmer J. P., Ensinck J. W. Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients. J Clin Endocrinol Metab. 1975 Sep;41(3):498–503. doi: 10.1210/jcem-41-3-498. [DOI] [PubMed] [Google Scholar]
  17. Palmer J. P., Walter R. M., Ensinck J. W. Arginine-stimulated acute phase of insulin and glucagon secretion. I. in normal man. Diabetes. 1975 Aug;24(8):735–740. doi: 10.2337/diab.24.8.735. [DOI] [PubMed] [Google Scholar]
  18. Porte D., Jr, Pupo A. A. Insulin responses to glucose: evidence for a two pool system in man. J Clin Invest. 1969 Dec;48(12):2309–2319. doi: 10.1172/JCI106197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Robertson R. P., Porte D., Jr The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest. 1973 Apr;52(4):870–876. doi: 10.1172/JCI107251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Seltzer H. S., Allen E. W., Herron A. L., Jr, Brennan M. T. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest. 1967 Mar;46(3):323–335. doi: 10.1172/JCI105534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Simpson R. G., Benedetti A., Grodsky G. M., Karam J. H., Forsham P. H. Early phase of insulin release. Diabetes. 1968 Nov;17(11):684–692. doi: 10.2337/diab.17.11.684. [DOI] [PubMed] [Google Scholar]
  22. Thorell J. I., Nosslin B., Sterky G. Estimation of the early insulin response to intravenous glucose injection. J Lab Clin Med. 1973 Jul;82(1):101–110. [PubMed] [Google Scholar]
  23. Unger R. H., Aguilar-Parada E., Müller W. A., Eisentraut A. M. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest. 1970 Apr;49(4):837–848. doi: 10.1172/JCI106297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Valverde I., Dobbs R., Unger R. H. Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs. Metabolism. 1975 Sep;24(9):1021–1028. doi: 10.1016/0026-0495(75)90095-5. [DOI] [PubMed] [Google Scholar]
  25. Varsano-Aharon N., Echemendia E., Yalow R. S., Berson S. A. Early insulin responses to glucose and to tolbutamide in maturity-onset diabetes. Metabolism. 1970 Jun;19(6):409–417. doi: 10.1016/0026-0495(70)90092-2. [DOI] [PubMed] [Google Scholar]
  26. Vinik A. I., Kalk W. J., Jackson W. P. A unifying hypothesis for hereditary and acquired diabetes. Lancet. 1974 Mar 23;1(7856):485–487. doi: 10.1016/s0140-6736(74)92788-3. [DOI] [PubMed] [Google Scholar]
  27. Walter R. M., Dudl R. J., Palmer J. P., Ensinck J. W. The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man. J Clin Invest. 1974 Nov;54(5):1214–1220. doi: 10.1172/JCI107864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Weir G. C., Knowlton S. D., Martin D. B. Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines. J Clin Invest. 1974 Dec;54(6):1403–1412. doi: 10.1172/JCI107887. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES